ArticleNature cancer2022
Author Correction: Ectopic JAK-STAT activation enables the transition to a stem-like and multilineage state conferring AR-targeted therapy resistance.
Abstract readPublished Erratum
In one paragraph
Article in Nature cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Ferroptosis vulnerability of enzalutamide resistant prostate cancer conferred by ACSL4 overexpression and GPX4 antagonism.Cell death & disease · 2026Article
- Lineage plasticity and histological transformation: tumor histology as a spectrum.Cell research · 2025Review
- Interferon-γ/Janus Kinase 1/STAT1 Signaling Represses Forkhead Box A1 and Drives a Basal Transcriptional State in Muscle-Invasive Bladder Cancer.The American journal of pathology · 2025Article
- JAK/STAT signaling maintains an intermediate cell population during prostate basal cell fate determination.Nature genetics · 2024Article
- Lineage Plasticity: The New Cancer Hallmark on the Block.Cancer research · 2024Review
Corrections and comments
- Erratum for
Authors and funding
26 authors.
Su Deng *Department of Molecular Biology, UT Southwestern Medical Center, Dallas, TX, USA.
Choushi Wang *Department of Molecular Biology, UT Southwestern Medical Center, Dallas, TX, USA.ORCID http://orcid.org/0000-0002-6667-1689
Yunguan Wang *Quantitative Biomedical Research Center, Department of Population and Data Sciences, UT Southwestern Medical Center, Dallas, TX, USA.
Yaru XuDepartment of Molecular Biology, UT Southwestern Medical Center, Dallas, TX, USA.
Xiaoling LiDepartment of Molecular Biology, UT Southwestern Medical Center, Dallas, TX, USA.
Nickolas A JohnsonDepartment of Molecular Biology, UT Southwestern Medical Center, Dallas, TX, USA.
Atreyi MukherjiDepartment of Molecular Biology, UT Southwestern Medical Center, Dallas, TX, USA.
U-Ging LoDepartment of Urology, UT Southwestern Medical Center, Dallas, TX, USA.
Lingfan XuDepartment of Pathology, Duke University School of Medicine, Durham, NC, USA.
Julisa GonzalezDepartment of Molecular Biology, UT Southwestern Medical Center, Dallas, TX, USA.
Lauren A MetangDepartment of Molecular Biology, UT Southwestern Medical Center, Dallas, TX, USA.
Jianfeng YeLyda Hill Department of Bioinformatics, UT Southwestern Medical Center, Dallas, TX, USA.
Carla Rodriguez TiradoDepartment of Molecular Biology, UT Southwestern Medical Center, Dallas, TX, USA.
Kathia RodarteDepartment of Neuroscience, UT Southwestern Medical Center, Dallas, TX, USA.
Yinglu ZhouDepartment of Pathology, Duke University School of Medicine, Durham, NC, USA.
Zhiqun XieQuantitative Biomedical Research Center, Department of Population and Data Sciences, UT Southwestern Medical Center, Dallas, TX, USA.ORCID http://orcid.org/0000-0001-7163-7242
Carlos AranaWakeland Genomics Core, UT Southwestern Medical Center, Dallas, TX, USA.
Valli AnnamalaiDepartment of Molecular Biology, UT Southwestern Medical Center, Dallas, TX, USA.
Xihui LiuDepartment of Urology, UT Southwestern Medical Center, Dallas, TX, USA.ORCID http://orcid.org/0000-0002-9716-1032
Donald J Vander GriendDepartment of Pathology, The University of Illinois at Chicago, Chicago, IL, USA.ORCID http://orcid.org/0000-0003-4421-5698
Douglas StrandDepartment of Urology, UT Southwestern Medical Center, Dallas, TX, USA.ORCID http://orcid.org/0000-0002-0746-927X
Jer-Tsong HsiehDepartment of Urology, UT Southwestern Medical Center, Dallas, TX, USA.
Bo LiLyda Hill Department of Bioinformatics, UT Southwestern Medical Center, Dallas, TX, USA.ORCID http://orcid.org/0000-0002-8617-900X
Ganesh RajDepartment of Urology, UT Southwestern Medical Center, Dallas, TX, USA.ORCID http://orcid.org/0000-0001-5098-6347
Tao WangQuantitative Biomedical Research Center, Department of Population and Data Sciences, UT Southwestern Medical Center, Dallas, TX, USA.ORCID http://orcid.org/0000-0002-4355-149X
Ping MuDepartment of Molecular Biology, UT Southwestern Medical Center, Dallas, TX, USA. ping.mu@utsouthwestern.edu.ORCID http://orcid.org/0000-0003-0955-0896
Funding
Elucidating the Molecular Role of SYNCRIP in Prostate Cancer and AR Targeted Therapy ResistanceR37CA258730 · NCI · YALE UNIVERSITY · PI Ping Mu · 2021 to 2026
$2.7MFunction of the Stem Cell Transcription Factor Sox2 in Prostate CancerR01CA178431 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI VANDER GRIEND, DONALD JAMES · 2014 to 2018
$1.9MCancer Prevention and Research Institute of Texas (Cancer Prevention Research Institute of Texas) RP160157Cancer Prevention and Research Institute of Texas (Cancer Prevention Research Institute of Texas) RP190208Cancer Prevention and Research Institute of Texas (Cancer Prevention Research Institute of Texas) RP220473Cancer Prevention and Research Institute of Texas (Cancer Prevention Research Institute of Texas) RR170050Cancer Prevention and Research Institute of Texas (Cancer Prevention Research Institute of Texas) RR170079NCI NIH HHS R37 CA258730Prostate Cancer Foundation (PCF) 17YOUN12University of Texas Southwestern Medical Center (UT Southwestern) Cancer Center PilotUniversity of Texas Southwestern Medical Center (UT Southwestern) Endowed ScholarU.S. Department of Defense (United States Department of Defense) W81XWH-16-1-0474U.S. Department of Defense (United States Department of Defense) W81XWH18-1-0411U.S. Department of Defense (United States Department of Defense) W81XWH2110418U.S. Department of Defense (United States Department of Defense) W81XWH21-1-0520U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) 1P30CA142543U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) 1R01CA245318U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) 1R01CA258584U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) 1R37CA258730U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) 5R00CA218885U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) R01CA178431U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) T32C124334Welch Foundation I-2005-20190330
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.